Assessing prenatal hepatitis B screening in illinois with an inexpensive study design adaptable to other jurisdictions

American Journal of Public Health

Volumn 89, Issue 1, 1999, Pages 19-24

  Barr, David ^a   Hershow, Ronald ^a   Furner, Sylvia ^a   Handler, Arden ^a   Levy, Paul ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; ECONOMIC ASPECT; FEMALE; FETUS; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; NORMAL HUMAN; PRENATAL SCREENING; RELIABILITY; SCREENING TEST; UNITED STATES;

EID: 0032975780     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.89.1.19     Document Type: Article

References (19)

1. Shapiro CN. Epidemiology of hepatitis B. Pediatr Infect Dis J. 1993;12:433-437.
2. Viral hepatitis surveillance program. In: Hepatitis Sunvillunce. Atlanta. Ga: Centers for Disease Control and Prevention; 1994. Report 55.
3. Pastorek JG. The ABCs of hepatitis in pregnancy. Clin Obstet Gynecol. 1993;36:845-848.
4. Mulligan MJ, Stiehm ER. Neonatal hepatitis B infection: clinical and immunologic considerations. J Perinatol. 1994;12:2-9.
5. Centers for Disease Control. Protection against viral hepatitis: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep. 1990;39(RR-2):7-9.
6. Jonas MM, Reddy RK, DeMedina M, Schiff ER. Hepatitis B infection in a large municipal obstetric population: characterization and prevention of perinatal transmission. Am J Gastroenterol. 1990;85:277-280.
7. McQuillan GM, Townsend TR, Johannes CB, et al. Prevention of perinatal transmission of hepatitis B virus: the sensitivity, specificity, and predictive value of the recommended screening questions to detect high-risk women in an obstetric population. Am J Epidemiol. 1987;126:484-491.
8. Jonas MM, Schiff ER, O'Sullivan MJ, et al. Failure of Centers for Disease Control criteria to identify hepatitis B infection in a large municipal obstetrical population. Ann Intern Med. 1987;107:335-337.
9. Summers PR, Biswas MK, Pastorek JG, Pernoll ML, Smith LG, Bean BE. The pregnant hepatitis B carrier: evidence favoring comprehensive antepartum screening. Obstet Gynecol. 1987;69:701-704.
10. Greenspoon JS, Martin J, Greenspoon RL, McNamara BT. Necessity for routine obstetric screening for hepatitis B surface antigen. J Reprod Med. 1989;34:655-658.
11. Centers for Disease Control. Prevention of perinatal transmission of hepatitis B virus: perinatal screening of all pregnant women for hepatitis B surface antigen. MMWR Morb Mortal Wkly Rep. 1988;37:341-345.
12. Centers for Disease Control and Prevention. Maternal hepatitis B screening practices-California, Connecticut, Kansas, and United States, 1992-1993. MMWR Morb Mortal Wkly Rep. 1994;43:311-320.
13. Yusuf HR, Mahoney FJ, Shapiro CN, Mast EE, Polish L. Hospital-based evaluation of programs to prevent perinatal hepatitis B virus transmission. Arch Pediatr Adolesc Med. 1996;150:593-597.
14. American Hospital Association Guide. Chicago, Ill: American Hospital Association; 1993:A132-A149.
15. Levy PS, Lemeshow S. Sampling of Populations: Methods and Applications. New York, NY: John Wiley & Sons Inc; 1991.
16. Rosner B. Fundamentals of Biostatistics. 4th ed. Belmont, Mass: Duxbury Press; 1995.
17. 1993 Statistics. Springfield, Ill: Illinois Center for Health Statistics, Illinois Dept of Public Health; 1995.
18. Dinsmoor MJ, Gibbs RS. Prevalence of asymptomatic hepatitis B infection in pregnant Mexican-American women. Obstet Gynecol. 1990;76:239-240.
19. Fehrs LJ, Eisele L, Conrad R, Foster LR, Fleming D. Prevalence of hepatitis B markers among pregnant Hispanic women in migrant seasonal work in Oregon. Am J Public Health. 1988;78:971-972.